In the present study, we found that PIK3CA mutations were the most commonly observed alternations in Taiwanese patients with breast cancer, particularly in HR + HER2− breast tumors, accounting for 43.1% of cases. This evidence concerns the gene ERBB2 and breast neoplasm.